What Happened?
Lexington, -based Greenlight-Biosciences Retired David Kennedy as General Counsel
About the Company
Greenlight Biosciences aims to address some of the world`s biggest problems by delivering on the full potential of RNA for human health and agriculture. Our RNA platform allows us to research, design, and manufacture for human, animal, and plant health. In human health, this includes messenger RNA vaccines and therapeutics. In agriculture, this includes RNA to protect honeybees and a range of crops. The company`s platform is protected by numerous patents. GreenLight`s human health product candidates are in the pre-clinical stage, and its product candidates for the agriculture market are in the early stages of development or regulatory review. GreenLight is a public benefit corporation that trades under the ticker GRNA on Nasdaq.
About the Person
David Kennedy is General Counsel at Greenlight Biosciences. Previously, David held various senior legal leadership roles in the industry.
Info Source
News
Short Profile